Gastric and duodenal neuroendocrine tumours

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 6, 2012, Pages 719-735

  O'Toole, Dermot ^a   Delle Fave, Gianfranco ^b   Jensen, Robert T ^c  

^a ST JAMES S HOSPITAL   (Ireland)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Duodenal neuroendocrine tumours; Gastric neuroendocrine tumours; Gastrin; Neuroendocrine tumours; Stomach

Indexed keywords

NETAZEPIDE; TEMOZOLOMIDE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL FEATURE; DISEASE CLASSIFICATION; DUODENUM TUMOR; ENDOSCOPIC MUCOSAL RESECTION; GASTRINOMA; GASTROINTESTINAL ENDOSCOPY; HUMAN; MOLECULARLY TARGETED THERAPY; NEUROENDOCRINE TUMOR; NONHUMAN; PROGNOSIS; SOMATOSTATINOMA; STOMACH TUMOR; TOTAL STOMACH RESECTION;

EID: 84876111506     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2013.01.002     Document Type: Review

References (116)

1. I.M. Modlin, S.F. Moss, D.C. Chung, R.T. Jensen, and E. Snyderwine Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors J Natl Cancer Inst 100 2008 1282 1289
2. I.M. Modlin, S.F. Moss, K. Oberg, R. Padbury, R.J. Hicks, and B.I. Gustafsson Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management Med J Aust 193 2010 46 52
3. G. Fave, D.J. Kwekkeboom, E. Van Cutsem, G. Rindi, B. Kos-Kudla, and U. Knigge ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms Neuroendocrinology 95 2012 74 87
4. G. Rindi, O. Luinetti, M. Cornaggia, C. Capella, and E. Solcia Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study Gastroenterology 104 1993 994 1006
5. I.M. Modlin, K.D. Lye, and M.A. Kidd 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 99 2004 23 32
6. M. Ono, H. Sato, H. Kazumori, M. Yuki, M.A. Rumi, and C.F. Ortega-Cava Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats J Lab Clin Med 142 2003 364 371
7. N. Hodgson, L.G. Koniaris, A.S. Livingstone, and D. Franceschi Gastric carcinoids: a temporal increase with proton pump introduction Surg Endosc 19 2005 1610 1612
8. G. Delle Fave, G. Capurso, B. Annibale, and F. Panzuto Gastric neuroendocrine tumors Neuroendocrinology 80 Suppl. 1 2004 16 19
9. D.M. Pritchard, D. Berry, S.M. Przemeck, F. Campbell, S.W. Edwards, and A. Varro Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor Am J Physiol Gastrointest Liver Physiol 295 2008 G798 805
10. L. Vannella, E. Lahner, and B. Annibale Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal World J Gastroenterol 18 2012 1279 1285
11. A.D. Higham, L.A. Bishop, R. Dimaline, C.G. Blackmore, A.C. Dobbins, and A. Varro Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia Gastroenterology 116 1999 1310 1318
12. K. Borch, H. Renvall, and G. Liedberg Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia Gastroenterology 88 1985 638 648
13. R.W. Stockbrugger, G.G. Menon, J.O. Beilby, R.R. Mason, and P.B. Cotton Gastroscopic screening in 80 patients with pernicious anaemia Gut 24 1983 1141 1147
14. I.M. Modlin, C.J. Gilligan, G.P. Lawton, L.H. Tang, A.B. West, and U. Darr Gastric carcinoids. The Yale experience Arch Surg 130 1995 250 255 [discussion 255-256]
15. R.M. Thomas, J.H. Baybick, A.M. Elsayed, and L.H. Sobin Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients Cancer 73 1994 2053 2058
16. M. Marignani, G. Delle Fave, S. Mecarocci, C. Bordi, S. Angeletti, and G. D'Ambra High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study Am J Gastroenterol 94 1999 766 772
17. D. O'Toole Current trend: endocrine tumors of the stomach, small bowel, colon and rectum Gastroenterol Clin Biol 30 2006 276 291
18. D.A. Crosby, C.L. Donohoe, L. Fitzgerald, C. Muldoon, B. Hayes, and D. O'Toole Gastric neuroendocrine tumours Dig Surg 29 2012 331 348
19. E. Merola, A. Sbrozzi-Vanni, F. Panzuto, G. D'Ambra, E. Di Giulio, and E. Pilozzi Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate Neuroendocrinology 95 2011 207 213
20. G. Rindi, C. Azzoni, S. La Rosa, C. Klersy, D. Paolotti, and S. Rappel ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis Gastroenterology 116 1999 532 542
21. D. Thomas, A.V. Tsolakis, S. Grozinsky-Glasberg, M. Fraenkel, K. Alexandraki, and S. Sougioultzis Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors. Data from a multicenter study Eur J Endocrinol 16 2 2013 Jan 17 185 193
22. K. Borch, B. Ahren, H. Ahlman, S. Falkmer, G. Granerus, and L. Grimelius Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type Ann Surg 242 2005 64 73
23. S. Rappel, A. Altendorf-Hofmann, and M. Stolte Prognosis of gastric carcinoid tumours Digestion 56 1995 455 462
24. E. Solcia, G. Rindi, R. Buffa, R. Fiocca, and C. Capella Gastric endocrine cells: types, function and growth Regul Pept 93 2000 31 35
25. R.A. Gladdy, V.E. Strong, D. Coit, P.J. Allen, H. Gerdes, and J. Shia Defining surgical indications for type I gastric carcinoid tumor Ann Surg Oncol 16 2009 3154 3160
26. M. Schindl, K. Kaserer, and B. Niederle Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment Arch Surg 136 2001 49 54
27. G. Rindi, C. Bordi, S. Rappel, S. La Rosa, M. Stolte, and E. Solcia Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior World J Surg 20 1996 168 172
28. G.F. Dakin, R.R. Warner, A. Pomp, B. Salky, and W.B. Inabnet Presentation, treatment, and outcome of type 1 gastric carcinoid tumors J Surg Oncol 93 2006 368 372
29. P.H. Jordan Jr., A. Barroso, and J. Sweeney Gastric carcinoids in patients with hypergastrinemia J Am Coll Surg 199 2004 552 555
30. J.A. Norton, M.L. Melcher, F. Gibril, and R.T. Jensen Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment Surgery 136 2004 1267 1274
31. J.A. Norton, R.S. Warren, M.G. Kelly, M.B. Zuraek, and R.T. Jensen Aggressive surgery for metastatic liver neuroendocrine tumors Surgery 134 2003 1057 1063 [discussion 1063-1055]
32. L.V. Debelenko, M.R. Emmert-Buck, Z. Zhuang, E. Epshteyn, C.A. Moskaluk, and R.T. Jensen The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids Gastroenterology 113 1997 773 781
33. M.J. Berna, B. Annibale, M. Marignani, T.V. Luong, V. Corleto, and A. Pace A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors J Clin Endocrinol Metab 93 2008 1582 1591
34. S.K. Agarwal, P.A. Kennedy, P.C. Scacheri, E.A. Novotny, A.B. Hickman, and A. Cerrato Menin molecular interactions: insights into normal functions and tumorigenesis Horm Metab Res 37 2005 369 374
35. P.L. Peghini, B. Annibale, C. Azzoni, M. Milione, V.D. Corleto, and F. Gibril Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas Gastroenterology 123 2002 68 85
36. I.M. Modlin, K.D. Lye, and M. Kidd Carcinoid tumors of the stomach Surg Oncol 12 2003 153 172
37. T. D'Adda, G. Keller, C. Bordi, and H. Hofler Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome Lab Invest 79 1999 671 677
38. C.J. Gilligan, G.P. Lawton, L.H. Tang, A.B. West, and I.M. Modlin Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion Am J Gastroenterol 90 1995 338 352
39. A.V. Safatle-Ribeiro, U. Ribeiro Jr., C.E. Corbett, K. Iriya, C.H. Kobata, and P. Sakai Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors Eur J Gastroenterol Hepatol 19 2007 21 28
40. M. Kidd, I.M. Modlin, G.N. Eick, R.L. Camp, and S.M. Mane Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development Am J Physiol Gastrointest Liver Physiol 292 2007 G191 200
41. M. Kidd, I.M. Modlin, S.M. Mane, R.L. Camp, and M.D. Shapiro Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease Ann Surg 243 2006 273 280
42. M. Kidd, I.M. Modlin, S.M. Mane, R.L. Camp, G.N. Eick, and I. Latich Utility of molecular genetic signatures in the delineation of gastric neoplasia Cancer 106 2006 1480 1488
43. R. Attanoos, and G.T. Williams Epithelial and neuroendocrine tumors of the duodenum Semin Diagn Pathol 8 1991 149 162
44. E.D. Williams, and M. Sandler The classification of carcinoid tum ours Lancet 1 1963 238 239
45. I.M. Modlin, K.D. Lye, and M. Kidd A 5-decade analysis of 13,715 carcinoid tumors Cancer 97 2003 934 959
46. R.T. Jensen, G. Rindi, R. Arnold, J.M. Lopes, M.L. Brandi, and W.O. Bechstein Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas) Neuroendocrinology 84 2006 165 172
47. J.C. Yao, M. Hassan, A. Phan, C. Dagohoy, C. Leary, and J.E. Mares One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 2008 3063 3072
48. G. Kloppel, A. Perren, and P.U. Heitz The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification Ann N Y Acad Sci 1014 2004 13 27
49. K.M. Hoffmann, M. Furukawa, and R.T. Jensen Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment Best Pract Res Clin Gastroenterol 19 2005 675 697
50. E. Hatzitheoklitos, M.W. Buchler, H. Friess, B. Poch, M. Ebert, and W. Mohr Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features Cancer 73 1994 1580 1588
51. G.F. Walton, E.R. Gibbs, G.O. Spencer, and H.L. Laws Carcinoid tumors of the ampulla of Vater Am Surg 63 1997 302 304
52. L. Bornstein-Quevedo, and A. Gamboa-Dominguez Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison Hum Pathol 32 2001 1252 1256
53. H. Witzigmann, C. Loracher, F. Geissler, T. Wagner, A. Tannapfel, and D. Uhlmann Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy Langenbecks Arch Surg 386 2002 525 533
54. W.M. Clements, S.P. Martin, G. Stemmerman, and A.M. Lowy Ampullary carcinoid tumors: rationale for an aggressive surgical approach J Gastrointest Surg 7 2003 773 776
55. M. Hartel, M.N. Wente, B. Sido, H. Friess, and M.W. Buchler Carcinoid of the ampulla of Vater J Gastroenterol Hepatol 20 2005 676 681
56. G.L. Taccagni, M. Carlucci, M. Sironi, A. Cantaboni, and V. Di Carlo Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study Am J Gastroenterol 81 1986 33 37
57. B.A. Swinburn, M.L. Yeong, M.R. Lane, G.I. Nicholson, and I.M. Holdaway Neurofibromatosis associated with somatostatinoma: a report of two patients Clin Endocrinol (Oxf) 28 1988 353 359
58. A.P. Burke, B.H. Federspiel, L.H. Sobin, K.M. Shekitka, and E.B. Helwig Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors Am J Surg Pathol 13 1989 828 837
59. J. Soga, and Y. Yakuwa Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas J Exp Clin Cancer Res 18 1999 13 22
60. B.T. Green, and D.C. Rockey Duodenal somatostatinoma presenting with complete somatostatinoma syndrome J Clin Gastroenterol 33 2001 415 417
61. R.F. Weichert 3rd, L.M. Roth, E.T. Krementz, R.L. Hewitt, and T. Drapanas Carcinoid-islet cell tumors of the duodenum. Report of twenty-one cases Am J Surg 121 1971 195 205
62. A. Lasson, A. Alwmark, A. Nobin, and F. Sundler Endocrine tumors of the duodenum. Clinical characteristics and hormone content Ann Surg 197 1983 393 398
63. B. Stamm, C.E. Hedinger, and P. Saremaslani Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen's disease (neurofibromatosis) Virchows Arch A Pathol Anat Histopathol 408 1986 475 489
64. C. Capella, C. Riva, G. Rindi, L. Usellini, A. Chiaravalli, and E. Solcia Endocrine tumors of the duodenum and upper jejunum. A study of 33 cases with clinico-pathological characteristics and hormone content Hepatogastroenterology 37 1990 247 252
65. A.P. Burke, L.H. Sobin, B.H. Federspiel, K.M. Shekitka, and E.B. Helwig Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases Arch Pathol Lab Med 114 1990 700 704
66. J. Soga Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases J Exp Clin Cancer Res 22 2003 349 363
67. H.C. Weber, D.J. Venzon, J.T. Lin, V.A. Fishbein, M. Orbuch, and D.B. Strader Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study Gastroenterology 108 1995 1637 1649
68. J.A. Norton, H.R. Alexander, D.L. Fraker, D.J. Venzon, F. Gibril, and R.T. Jensen Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome? Ann Surg 239 2004 617 625 [discussion 626]
69. F. Gibril, M. Schumann, A. Pace, and R.T. Jensen Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature Medicine (Baltimore) 83 2004 43 83
70. R.T. Jensen Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1 J Intern Med 243 1998 477 488
71. S. Amano, F. Hazama, H. Haebara, M. Tsurusawa, and H. Kaito Ectopic ACTH-MSH producing carcinoid tumor with multiple endocrine hyperplasia in a child Acta Pathol Jpn 28 1978 721 730
72. N.J. Zyromski, M.L. Kendrick, D.M. Nagorney, C.S. Grant, J.H. Donohue, and M.B. Farnell Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg 5 2001 588 593
73. H.Y. Wang, M.J. Chen, T.L. Yang, M.C. Chang, and Y.J. Chan Carcinoid tumor of the duodenum and accessory papilla associated with polycythemia vera World J Gastroenterol 11 2005 3794 3796
74. Y. Dayal, K.A. Tallberg, G. Nunnemacher, R.A. DeLellis, and H.J. Wolfe Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study Am J Surg Pathol 10 1986 348 357
75. I. Hatzaras, J.A. Palesty, F. Abir, P. Sullivan, R.A. Kozol, and S.J. Dudrick Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry Arch Surg 142 2007 229 235
76. J. Soga, K. Tazawa, O. Aizawa, K. Wada, and T. Tuto Argentaffin cell adenocarcinoma of the stomach: an atypical carcinoid? Cancer 28 1971 999 1003
77. M. Papotti, P. Cassoni, M. Volante, R. Deghenghi, G. Muccioli, and E. Ghigo Ghrelin-producing endocrine tumors of the stomach and intestine J Clin Endocrinol Metab 86 2001 5052 5059
78. B. Annibale, C. Azzoni, V.D. Corleto, E. di Giulio, P. Caruana, and G. D'Ambra Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid Eur J Gastroenterol Hepatol 13 2001 1449 1456
79. M. Dinis-Ribeiro, M. Areia, A.C. de Vries, R. Marcos-Pinto, M. Monteiro-Soares, and A. O'Connor Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) Endoscopy 44 2012 74 94
80. E. Solcia, C. Bordi, W. Creutzfeldt, Y. Dayal, A.D. Dayan, and S. Falkmer Histopathological classification of nonantral gastric endocrine growths in man Digestion 41 1988 185 200
81. D. Cattan, and A.M. Roucayrol Fundic endocrinopathy in fundic atrophic gastritis with achlorhydria. II-Carcinoid tumors Gastroenterol Clin Biol 15 1991 36C 40C
82. C. Bordi, J.Y. Yu, M.T. Baggi, C. Davoli, F.P. Pilato, and G. Baruzzi Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases Cancer 67 1991 663 672
83. T. Lehy, G. Cadiot, M. Mignon, P. Ruszniewski, and S. Bonfils Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome Gut 33 1992 1275 1279
84. G. Rindi, R. Arnold, and F.T. Bosman Nomenclature and classification of neuroendocrine neoplasms of the digestive system F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumors of the digestive system 2010 IARC Lyon
85. E. Solcia, G. Klöppel, and L.H. Sobin Histological typing of endocrine tumours 2000 Springer New York
86. J. Alumets, F. Sundler, S. Falkmer, O. Ljungberg, R. Hakanson, and H. Martensson Neurohormonal peptides in endocrine tumors of the pancreas, stomach, and upper small intestine: I. An immunohistochemical study of 27 cases Ultrastruct Pathol 5 1983 55 72
87. M.F. Heymann, A. Hamy, S. Triau, E. Miraille, C. Toquet, and H. Chomarat Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content Hepatogastroenterology 51 2004 1367 1371
88. M. Barbareschi, B. Frigo, D. Aldovini, E. Leonardi, S. Cristina, and M. Falleni Duodenal gangliocytic paraganglioma. Report of a case and review of the literature Virchows Arch A Pathol Anat Histopathol 416 1989 81 89
89. S. La Rosa, F. Inzani, A. Vanoli, C. Klersy, L. Dainese, and G. Rindi Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms Hum Pathol 42 2012 1373 1384
90. R. Kumashiro, H. Naitoh, K. Teshima, T. Sakai, and S. Inutsuka Minute gastric carcinoid tumor with regional lymph node metastasis Int Surg 74 1989 198 200
91. S.D. Xie, L.B. Wang, X.Y. Song, and T. Pan Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature World J Gastroenterol 10 2004 2461 2463
92. J. Soga Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases Cancer 103 2005 1587 1595
93. C. Bordi Gastric carcinoids Ital J Gastroenterol Hepatol 31 Suppl. 2 1999 S94 97
94. D.B. Gough, G.B. Thompson, T.B. Crotty, J.H. Donohue, L.K. Kvols, and J.A. Carney Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia World J Surg 18 1994 473 479 [discussion 479-480]
95. J. Dalenback, and G. Havel Local endoscopic removal of duodenal carcinoid tumors Endoscopy 36 2004 651 655
96. J. Ichikawa, S. Tanabe, W. Koizumi, Y. Kida, H. Imaizumi, and M. Kida Endoscopic mucosal resection in the management of gastric carcinoid tumors Endoscopy 35 2003 203 206
97. A.D. Higham, R. Dimaline, A. Varro, S. Attwood, G. Armstrong, and G.J. Dockray Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor Gastroenterology 114 1998 817 822
98. Murugesan SV, Steele IA, Dimaline R, Poston GJ, Shrotri M, Campbell F, et al. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours. Eur J Gastroenterol Hepatol.
99. P. Ruszniewski, H. Laucournet, L. Elouaer-Blanc, M. Mignon, and S. Bonfils Long-acting somatostatin (SMS 201-995) in the management of Zollinger-Ellison syndrome: evidence for sustained efficacy Pancreas 3 1988 145 152
100. S. Grozinsky-Glasberg, G. Kaltsas, C. Gur, E. Gal, D. Thomas, and S. Fichman Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours Eur J Endocrinol 159 2008 475 482
101. S. Manfredi, M. Pagenault, A.S. de Lajarte-Thirouard, and J.F. Bretagne Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue Eur J Gastroenterol Hepatol 19 2007 1021 1025
102. S. Massironi, V. Sciola, M.P. Spampatti, M. Peracchi, and D. Conte Gastric carcinoids: between underestimation and overtreatment World J Gastroenterol 15 2009 2177 2183
103. C.S. Jianu, R. Fossmark, U. Syversen, O. Hauso, V. Fykse, and H.L. Waldum Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids Scand J Gastroenterol 46 2011 456 463
104. T.C. Martinsen, S. Kawase, R. Hakanson, S.H. Torp, R. Fossmark, and G. Qvigstad Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist Carcinogenesis 24 2003 1887 1896
105. S. Takaishi, G. Cui, D.M. Frederick, J.E. Carlson, J. Houghton, and A. Varro Synergistic inhibitory effects of gastrin and histamine receptor antagonists on helicobacter-induced gastric cancer Gastroenterology 128 2005 1965 1983
106. M. Kidd, Z.L. Siddique, I. Drozdov, B.I. Gustafsson, R.L. Camp, and J.W. Black The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development Regul Pept 162 2010 52 60
107. Fossmark R, Sordal O, Jianu CS, Qvigstad G, Nordrum IS, Boyce M, et al. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther;36:1067-75.
108. J.A. Norton, J.L. Doppman, and R.T. Jensen Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study Ann Surg 215 1992 8 18
109. J.A. Norton, and R.T. Jensen Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome Ann Surg 240 2004 757 773
110. J.T. Mullen, H. Wang, J.C. Yao, J.H. Lee, N.D. Perrier, and P.W. Pisters Carcinoid tumors of the duodenum Surgery 138 2005 971 977 [discussion 977-978]
111. H.R. Makhlouf, A.P. Burke, and L.H. Sobin Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors Cancer 85 1999 1241 1249
112. D. O'Toole, G. Rindi, U. Plockinger, and B. Wiedenmann ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. Introduction Neuroendocrinology 91 2010 324 325
113. Pavel M, Baudin E, Couvelard A, Krenning E, Oberg K, Steinmuller T, et al. ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology;95:157-76.
114. D.J. Kwekkeboom, J.J. Teunissen, W.H. Bakker, P.P. Kooij, W.W. de Herder, and R.A. Feelders Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors J Clin Oncol 23 2005 2754 2762
115. G. Rindi, G. Kloppel, H. Alhman, M. Caplin, A. Couvelard, and W.W. de Herder TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 2006 395 401
116. L.H. Sobin, and C. Wittekind TNM classification of malignant tumours 2002 Wiley-Liss New York